0576-88813233
利妥昔单抗Rituximab是用于治疗某些自身免疫疾病和癌症类型的抗CD20嵌合单克隆抗体。
中文别名:
3-羟基-2-(吡啶-4-基)茚-1-酮;
3-羟基-2-(吡啶-4-基)-1H-茚-1-酮
[1]. Kamburova EG, et al. In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells. Am J Transplant. 2012 Feb;12(2):341-50.
[2]. Manches O, et al. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood. 2003 Feb 1;101(3):949-54.
版权所有 Copyright(C) 2018-2024 台州市科瑞生物技术有限公司